True Health Medical Technology Launches HK$483 Million Hong Kong IPO

MT Newswires Live06-22 09:33

Guangdong True Health Medical Technology Development (HKG:2697) launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$482.7 million.

The China-based surgical robotics company is offering 3.6 million H shares at a maximum price of HK$135.40 each, according to a Hong Kong bourse filing.

The offering comprises 356,480 shares for Hong Kong investors and 3.2 million shares for international investors, subject to reallocation and the over-allotment option.

The offer price is expected to be determined by June 26, with allocation results due by June 29, ahead of the company's planned trading debut on June 30.

Net proceeds will be used primarily to fund the research, development, and commercialization of True Health Medical's core surgical robotics product.

The company also plans to use the funds to advance key and other pipeline products, expand manufacturing capacity and production capabilities, and for working capital and general corporate purposes.

CICC Hong Kong Securities, DBS Asia Capital, ABCI Capital, Funde Securities, CMBC Securities, Livermore Holdings, Open Securities and SPDB International Capital are serving as joint bookrunners, according to the prospectus.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2645012212?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-22 09:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645012212","market":"sh","top_or_hot":-1,"title":"True Health Medical Technology Launches HK$483 Million Hong Kong IPO","media":"MT Newswires Live","content":"<html><body><p> Guangdong True Health Medical Technology Development (HKG:2697) launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$482.7 million.</p><p>The China-based surgical robotics company is offering 3.6 million H shares at a maximum price of HK$135.40 each, according to a Hong Kong bourse filing.</p><p>The offering comprises 356,480 shares for Hong Kong investors and 3.2 million shares for international investors, subject to reallocation and the over-allotment option.</p><p>The offer price is expected to be determined by June 26, with allocation results due by June 29, ahead of the company's planned trading debut on June 30.</p><p>Net proceeds will be used primarily to fund the research, development, and commercialization of True Health Medical's core surgical robotics product.</p><p>The company also plans to use the funds to advance key and other pipeline products, expand manufacturing capacity and production capabilities, and for working capital and general corporate purposes.</p><p>CICC Hong Kong Securities, DBS Asia Capital, ABCI Capital, Funde Securities, CMBC Securities, Livermore Holdings, Open Securities and SPDB International Capital are serving as joint bookrunners, according to the prospectus.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>True Health Medical Technology Launches HK$483 Million Hong Kong IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTrue Health Medical Technology Launches HK$483 Million Hong Kong IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-22 09:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Guangdong True Health Medical Technology Development (HKG:2697) launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$482.7 million.</p><p>The China-based surgical robotics company is offering 3.6 million H shares at a maximum price of HK$135.40 each, according to a Hong Kong bourse filing.</p><p>The offering comprises 356,480 shares for Hong Kong investors and 3.2 million shares for international investors, subject to reallocation and the over-allotment option.</p><p>The offer price is expected to be determined by June 26, with allocation results due by June 29, ahead of the company's planned trading debut on June 30.</p><p>Net proceeds will be used primarily to fund the research, development, and commercialization of True Health Medical's core surgical robotics product.</p><p>The company also plans to use the funds to advance key and other pipeline products, expand manufacturing capacity and production capabilities, and for working capital and general corporate purposes.</p><p>CICC Hong Kong Securities, DBS Asia Capital, ABCI Capital, Funde Securities, CMBC Securities, Livermore Holdings, Open Securities and SPDB International Capital are serving as joint bookrunners, according to the prospectus.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02697","symbol_name":"真健康医疗-B","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2645012212","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645012212","pubTimestamp":1782091984,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Guangdong True Health Medical Technology Development  launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$482.7 million.The China-based surgical robotics company is offering 3.6 million H shares at a maximum price of HK$135.40 each, according to a Hong Kong bourse filing.The offering comprises 356,480 shares for Hong Kong investors and 3.2 million shares for international investors, subject to reallocation and the over-allotment option.The offer price is expected to be determined by June 26, with allocation results due by June 29, ahead of the company's planned trading debut on June 30.Net proceeds will be used primarily to fund the research, development, and commercialization of True Health Medical's core surgical robotics product.The company also plans to use the funds to advance key and other pipeline products, expand manufacturing capacity and production capabilities, and for working capital and general corporate purposes.CICC Hong Kong Securities, D","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02697":"真健康医疗-B","IPOS":"Renaissance International IPO ETF"},"translate_title":"真健康医疗科技4.83亿港元香港IPO","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02697":0.9,"IPOS":1.5},"content_text":"Guangdong True Health Medical Technology Development (HKG:2697) launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$482.7 million.The China-based surgical robotics company is offering 3.6 million H shares at a maximum price of HK$135.40 each, according to a Hong Kong bourse filing.The offering comprises 356,480 shares for Hong Kong investors and 3.2 million shares for international investors, subject to reallocation and the over-allotment option.The offer price is expected to be determined by June 26, with allocation results due by June 29, ahead of the company's planned trading debut on June 30.Net proceeds will be used primarily to fund the research, development, and commercialization of True Health Medical's core surgical robotics product.The company also plans to use the funds to advance key and other pipeline products, expand manufacturing capacity and production capabilities, and for working capital and general corporate purposes.CICC Hong Kong Securities, DBS Asia Capital, ABCI Capital, Funde Securities, CMBC Securities, Livermore Holdings, Open Securities and SPDB International Capital are serving as joint bookrunners, according to the prospectus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2645012212","isCrawlerRequest":true}